|248.39||+0.0400||+0.02%||Vol 2.98M||1Y Perf 8.85%|
|Aug 12th, 2022 16:00 DELAYED|
|- -||-1.11 -0.45%|
|Target Price||250.87||Analyst Rating||Hold 2.67|
|Potential %||1.00||Finscreener Ranking||+ 36.86|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★+ 43.45|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★+ 49.05|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||★+ 36.36|
|Price Range Ratio 52W %||83.18||Earnings Rating||Sell|
|Market Cap||132.87B||Earnings Date||4th Aug 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||4.36|
|EPS Growth Next 5 Years %||7.20|
|Avg. Weekly Volume||2.57M|
|Avg. Monthly Volume||2.36M|
|Avg. Quarterly Volume||2.88M|
Amgen Inc. (NASDAQ: AMGN) stock closed at 248.39 per share at the end of the most recent trading day (a 0.02% change compared to the prior day closing price) with a volume of 2.98M shares and market capitalization of 132.87B. Is a component of S&P 500, NASDAQ 100, Dow Jones 30, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 24300 people. Amgen Inc. CEO is Robert A. Bradway.
The one-year performance of Amgen Inc. stock is 8.85%, while year-to-date (YTD) performance is 10.41%. AMGN stock has a five-year performance of 46.6%. Its 52-week range is between 198.64 and 258.45, which gives AMGN stock a 52-week price range ratio of 83.18%
Amgen Inc. currently has a PE ratio of 21.10, a price-to-book (PB) ratio of 54.92, a price-to-sale (PS) ratio of 5.04, a price to cashflow ratio of 14.80, a PEG ratio of 2.32, a ROA of 11.73%, a ROC of 19.20% and a ROE of 135.49%. The company’s profit margin is 24.75%, its EBITDA margin is 45.90%, and its revenue ttm is $26.38 Billion , which makes it $49.32 revenue per share.
Of the last four earnings reports from Amgen Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $4.36 for the next earnings report. Amgen Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Amgen Inc. is Hold (2.67), with a target price of $250.87, which is +1.00% compared to the current price. The earnings rating for Amgen Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Amgen Inc. has a dividend yield of 3.12% with a dividend per share of $7.76 and a payout ratio of 54.00%.
Amgen Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 6.92, ATR14 : 4.07, CCI20 : 23.15, Chaikin Money Flow : 0.06, MACD : 0.96, Money Flow Index : 41.16, ROC : -1.32, RSI : 55.28, STOCH (14,3) : 55.11, STOCH RSI : 0.16, UO : 55.40, Williams %R : -44.89), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Amgen Inc. in the last 12-months were: Jonathan P. Graham (Sold 13 500 shares of value $3 264 454 ), Robert Sanders Williams (Sold 600 shares of value $150 000 )
Wed, 13 Jul 2022 12:25 GMT Amgen (AMGN) Receives a Buy from Jefferies- TipRanks. All rights reserved.
Wed, 13 Jul 2022 12:16 GMT Analysts Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Sorrento Therapeutics (SRNE)- TipRanks. All rights reserved.
Tue, 24 May 2022 02:05 GMT Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), ImmunoGen (IMGN) and Guardant Health (GH)- TipRanks. All rights reserved.
Wed, 27 Apr 2022 21:15 GMT Amgen (AMGN) Receives a Hold from Mizuho Securities- TipRanks. All rights reserved.
Tue, 19 Apr 2022 09:02 GMT Jefferies Believes Amgen (AMGN) Wont Stop Here- TipRanks. All rights reserved.
Thu, 03 Mar 2022 10:21 GMT Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), DENTSPLY SIRONA (XRAY) and Viatris (VTRS)- TipRanks. All rights reserved.
Mon, 28 Feb 2022 15:16 GMT Amgens Three-Pronged Approach for Creating Shareholder Value- TipRanks. All rights reserved.
Fri, 18 Feb 2022 09:46 GMT What Do Amgens Newly Added Risk Factors Reveal- TipRanks. All rights reserved.
Tue, 08 Feb 2022 13:45 GMT Analysts Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Electromed (ELMD) and Pfizer (PFE)- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.